Clifton Fuller
M.D. Anderson Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
4
all conditions, ClinicalTrials.gov
NIH grants tied to them
9
5 more share only the name and are not shown
Trial papers
74
PubMed author-name match
Trials
Studies that name Clifton Fuller as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 00:05 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06912763 · Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)M.D. Anderson Cancer Center · recruiting · Fibrosis Syndrome, Lymphedema, Head &Amp; Neck Cancer · principal investigator
- Ph2NCT06494111 · Systemic Therapy of Open-label Prophylactic Pravastatin or Pentoxifylline/Tocopherol Prevention of Lymphedema Advancing to Eventual Fibrosis: an Interventional Registry-embedded Bayesian Randomized Trial for Radiation Sequelae (STOP4-LATE-FIBROSE)M.D. Anderson Cancer Center · recruiting · Lymphedema, Fibrosis · principal investigator
- Ph2NCT03224000 · Trial of Magnetic Resonance Imaging Guided Radiotherapy Dose Adaptation in Human Papilloma Virus Positive Oropharyngeal CancerM.D. Anderson Cancer Center · active not recruiting · Malignant Neoplasms of Lip Oral Cavity and Pharynx, Oropharyngeal Cancer · principal investigator
- Early Ph1NCT01895829 · Ferumoxytol - Iron Oxide Nanoparticle Magnetic Resonance Dynamic Contrast Enhanced MRIM.D. Anderson Cancer Center · terminated · Head and Neck Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 00:05 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 5 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Harvard MD Anderson Collaborative to Reduce LyMphatic MOrbidity in Head and Neck Cancer with Artificial Intelligence (HARMONiC-AI)R01DE034780 · NIDCR · UNIVERSITY OF TX MD ANDERSON CAN CTR · fiscal years 2025 to 2026 · $716,638 awarded in 2026Same name and institution; not confirmed by an ID
- Image Guided Cancer Therapy Training ProgramT32CA261856 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · fiscal years 2022 to 2026 · $93,165 awarded in 2026Same name and institution; not confirmed by an ID
- InHANCE: Imaging Innovation for Head And Neck Cancer Evaluation & Treatment DeliveryP01CA278716 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · fiscal years 2025 to 2026 · $2,326,624 awarded in 2026Same name and institution; not confirmed by an ID
- OPC SURVIVOR: Optimizing OroPharyngeal Cancer SURVIVORshipP01CA285249 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · fiscal years 2024 to 2026 · $2,320,910 awarded in 2026Same name and institution; not confirmed by an ID
- Quantitative Imaging Biomarker Prospective Validation of Dynamic Contrast-Enhanced MRI as a Metric of Orodental Injury After Radiotherapy (QI-ProVE-MRI)U01DE032168 · NIDCR · UNIVERSITY OF TX MD ANDERSON CAN CTR · fiscal years 2023 to 2026 · $704,812 awarded in 2026Same name and institution; not confirmed by an ID
- Administrative Supplement for Probabilistic Deep Learning Cervical Lymph-Node Auto-Segmentation For Imaging-enhanced Evaluation of Extracapsular Extension Risk (PDL-CLASIFIER)R03DE033550 · NIDCR · UNIVERSITY OF TX MD ANDERSON CAN CTR · fiscal years 2024 to 2025 · $175,256 awarded in 2025Same name and institution; not confirmed by an ID
- Development of functional magnetic resonance imaging-guided adaptive radiotherapy for head and neck cancer patients using novel MR-Linac deviceR01DE028290 · NIDCR · UNIVERSITY OF TX MD ANDERSON CAN CTR · fiscal years 2019 to 2023 · $204,847 awarded in 2023Same name and institution; not confirmed by an ID
- Fellow and Resident Radiation Oncology iNtensive Training in Imaging and Informatics to Empower Research Careers (FRONTI2ER)R25EB025787 · NIBIB · UNIVERSITY OF TX MD ANDERSON CAN CTR · fiscal years 2018 to 2022 · $152,816 awarded in 2022Same name and institution; not confirmed by an ID
- imaging Radiation-Associated Dysphagia (iRAD)R01CA218148 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · fiscal years 2017 to 2019 · $217,667 awarded in 2019Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 00:05 UTC. The ranking covers the 200 most relevant of 74 PubMed records, and a shared surname and initials can bring in a namesake. All 74 on PubMed
- The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III).J Neurol Sci · 19992,882 citationsRCR 86.5
- 727 citationsRCR 15.7
- The effect of alpha-tocopherol supplementation on LDL oxidation. A dose-response study.Arterioscler Thromb Vasc Biol · 1995301 citationsRCR 10.7
- 195 citationsRCR 8.9
- 190 citationsRCR 9.2
- 177 citationsRCR 7.8
- Antipsychotic-induced insulin resistance and postprandial hormonal dysregulation independent of weight gain or psychiatric disease.Diabetes · 2013160 citationsRCR 5.8
- 146 citationsRCR 6.8
- 142 citationsRCR 6.5
- "The dirty hand in the latex glove": a study of hand hygiene compliance when gloves are worn.Infect Control Hosp Epidemiol · 2011122 citationsRCR 5.0